Venous Thromboembolism during Pregnancy and the Postpartum Period: Incidence, Risk Factors, and Mortality. Obstetric Anesthesia Digest 26(4): 174-175, 2006
Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics and Gynecology 194(5): 1311-1315, 2006
Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstetricia et Gynecologica Scandinavica 96(7): 852-861, 2017
OC-4b: Blood transfusion and postpartum hemorrhage as risk factors for postpartum venous thromboembolism. Thrombosis Research 151: S105-S106, 2017
A clinical risk score to predict the incidence of postpartum venous thromboembolism. Evidence-Based Medicine 22(3): 98, 2017
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine 162(10): 1182-1189, 2002
Cardiovascular risk factors and venous thromboembolism incidence The Longitudinal Investigation of Thromboembolism Etiology study. Circulation 102(18 Suppl.): II 861, October 31, 2000
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Journal of Thrombosis and Haemostasis 5(7): 1455-1461, 2007
Early Postpartum Venous Thromboembolism: Risk Factors and Predictive Index. Clinical and Applied Thrombosis/Hemostasis 2018: 1076029618818777-1076029618818777, 2018
Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism. Thrombosis Research 165: 54-60, 2018
Incidence and risk factors for venous thromboembolism. La Revue du Praticien 57(7): 711-3, 716, 719-20, 2007
Venous thromboembolism--incidence and risk factors in Oslo. Tidsskrift for den Norske Laegeforening 118(25): 3934-3938, 1998
Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England. Blood 124(18): 2872-2880, 2015
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism. British Journal of Haematology 133(1): 68-77, 2006
The incidence and risk factors of recurrent venous thromboembolism during pregnancy. Thrombosis Research 134(2): 240-245, 2015